Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...

The first evidence that removing amyloid plaques may delay Alzheimer’s symptoms has now been published. In The Lancet Neurology on March 19, scientists led by Randall Bateman at Washington University ...

With drugs on the horizon for treating and possibly preventing transthyretin amyloid cardiomyopathy, cardiologists are ...

Early-onset Alzheimer’s disease progresses more rapidly and often strikes people in the prime of their lives. A new treatment ...

Amyloid beta is a small protein fragment that forms plaque-like deposits when it accumulates abnormally in the brain. Vaccination is supposed to trigger the immune system to produce antibodies to ...

A new study suggests a promising alternative to previous attempts to remove the sticky, toxic amyloid beta plaques from brains with Alzheimer's Disease: enhancing the brain's own immune cells to ...

PET/CT, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more ...

3d rendered medically accurate illustration of amyloid plaques on a nerve cell - alzheimer disease Anti-amyloid drugs might be able to ward off Alzheimer’s disease In a small group, such a drug ...